He wouldn't apply for an EUA without a decent chan
Post# of 148280
At worst, they're submitting this now, and the FDA can give feedback, CytoDyn can patch holes and address anything else that happens to need addressing, and roll results from CD16 in and re-submit when the time comes. It would be the most prudent use of this time, imo.